|
|
|
|
|
Yuko Terada, Kenjiro Tanaka, Minami Matsuyama, Masaya Fujitani, Masatoshi Shibuya, Yoshihiko Yamamoto, Ryuji Kato and Keisuke Ito
Because transient receptor potential ankyrin 1 (TRPA1) is involved in various physiological functions, TRPA1-targeting drugs have been energetically developed. Although TRPA1 is considered a multimodal receptor, the structural diversity of TRPA1 agonists...
ver más
|
|
|
|
|